在75岁人口中逐步查心房动:对预防中风的影响
Johan Engdahl1, Lisbeth Andersson, Maria Mirskaya
1Department of Medicine, Hallands Hospital Halmstad, Sweden. johan.engdahl@regionhalland.se
Circulation
|January 25, 2013
概括
在75岁的患者中对未被诊断的心房动 (AF) 的查发现9%的人需要抗凝药. 这种逐步的方法有效地发现了中风预防治疗的候选人.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 老年病的医生 老年病的医生
背景情况:
- 心房动 (AF) 是通过心脏栓塞导致中风的常见原因.
- 未被诊断的AF具有很大的风险,因为它通常无症状.
- 在风险人群中选静音AF是合乎逻辑的,但缺乏关于产量和成本效益的数据.
研究的目的:
- 评估老年人AF逐步查计划的收益率.
- 为了确定口服抗凝治疗的候选人.
主要方法:
- 在瑞典哈尔姆斯塔德,75岁至76岁的年轻人实施了一项逐步查计划.
- 参与者接受了12次心电图和风险因素评估.
- 没有被诊断为AF但有风险因素的个体使用了手持心电图2周.
主要成果:
- 在848名参与者中,有10人 (1%) 之前未被诊断的静音AF被12导电图检测出来.
- 在那些有风险因素的患者中,有30人 (7.4%) 通过手持心电图被诊断出患有心肌梗塞.
- 总的来说,75名参与者 (9%) 被确定为口服抗凝药的候选人.
结论:
- 在75岁的老年人中,逐步进行风险分层的AF查是有效的.
- 查确定了大量适用于口服抗凝治疗的个体,有助于预防中风.
相关概念视频
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...


